Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 Gaucher disease

Affiliations

• ¹ Department of internal medicine, Hôpital Saint Joseph, Marseille, France. Electronic address: [email protected].
• ² Referal Center for Lysosomal Diseases, CHU Paris Nord Val de Seine, France.
• ³ EA 3279 Research Unit, Marseille, France.
• ⁴ Department of internal Medicine, CHU Hôpital Sud, Rennes, France.
• ⁵ Medical Intensive Care Unit, CHU Saint André, Bordeaux, France.
• ⁶ Clinical immunology and osteoarticular diseases Therapeutic Unit, CHRU Lapeyronie, Montpellier, France.
• ⁷ Department of gastroenterology, CHU Saint Eloi, Montpellier, France.
• ⁸ Department of internal Medicine, CHU Rouen, Rouen, France.
• ⁹ Department of hematology, CHU Estaing, Clermont Ferrand, France.